Archive - July 2023
Eli Lilly to acquire Versanis in deal worth over $1.9bn
Gilead’s COVID-19 treatment approved by FDA for patients with severe renal impairment
Acumen shares positive results for investigational Alzheimer’s disease therapy at AAIC
Alnylam presents promising results for RNAi therapeutic in Alzheimer’s disease at AAIC
NonStop Consulting: Directeur régional – Pionner et leader de son marché
Concussions Won’t Lower Your Kid’s IQ: Study
How Much of a Difference Is 988 Suicide & Crisis Line Making a Year After Its Launch?
Stretch Your Brain as You Age, Lower Your Dementia Risk?